These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 38519049)
61. [Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing]. Lyu Y; Han GH; Fan DM Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):402-407. PubMed ID: 28763854 [TBL] [Abstract][Full Text] [Related]
62. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension. Hosokawa I; Adam R; Allard MA; Pittau G; Vibert E; Cherqui D; Sa Cunha A; Bismuth H; Miyazaki M; Castaing D Br J Surg; 2017 Mar; 104(4):443-451. PubMed ID: 28079252 [TBL] [Abstract][Full Text] [Related]
63. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt. Zhong BY; Tang HH; Wang WS; Shen J; Zhang S; Li WC; Yin Y; Yang J; Liu F; Ni CF; Zhao JB; Zhu XL Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e153-e160. PubMed ID: 33177378 [TBL] [Abstract][Full Text] [Related]
64. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis. Orloff MJ; Hye RJ; Wheeler HO; Isenberg JI; Haynes KS; Vaida F; Girard B; Orloff KJ Surgery; 2015 Jun; 157(6):1028-45. PubMed ID: 25957003 [TBL] [Abstract][Full Text] [Related]
65. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience. Kraglund F; Jepsen P; Amanavicius N; Aagaard NK Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699 [No Abstract] [Full Text] [Related]
66. An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting. Bañares R; Albillos A; Nakum M; Gea S; Varghese A; Green W Adv Ther; 2023 Jul; 40(7):3006-3020. PubMed ID: 37160834 [TBL] [Abstract][Full Text] [Related]
67. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Rudler M; Cluzel P; Corvec TL; Benosman H; Rousseau G; Poynard T; Thabut D Aliment Pharmacol Ther; 2014 Nov; 40(9):1074-80. PubMed ID: 25230051 [TBL] [Abstract][Full Text] [Related]
68. Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding. Lv Y; Wang Z; Li K; Wang Q; Bai W; Yuan X; Yu T; Niu J; Yang Z; Zhu X; Zhao J; Xue H; Jiang Z; Zhuge Y; Zhang C; Sun J; Ding P; Ren W; Li Y; Zhang K; Zhang W; Guo W; Luo B; Li X; Yuan J; Han N; Zhu Y; He C; Yin Z; Fan D; Han G Hepatology; 2021 Apr; 73(4):1478-1493. PubMed ID: 32706906 [TBL] [Abstract][Full Text] [Related]
69. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt. Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750 [TBL] [Abstract][Full Text] [Related]
70. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ring EJ; Lake JR; Roberts JP; Gordon RL; LaBerge JM; Read AE; Sterneck MR; Ascher NL Ann Intern Med; 1992 Feb; 116(4):304-9. PubMed ID: 1733385 [TBL] [Abstract][Full Text] [Related]
71. Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials. Halabi SA; Sawas T; Sadat B; Jandali A; Halabi HA; Halabi FA; Kapoor B; Carey WD J Gastroenterol Hepatol; 2016 Sep; 31(9):1519-26. PubMed ID: 26858143 [TBL] [Abstract][Full Text] [Related]
72. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker. Chen Y; Ma X; Zhang X; Luo J; An L; Zhang Y; Chang X; Dong Z; Zhang W; Kong H; Zhao J; Ding H; Liu F; Yang Y Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564 [TBL] [Abstract][Full Text] [Related]
73. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916 [TBL] [Abstract][Full Text] [Related]
74. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Pomier-Layrargues G; Villeneuve JP; Deschênes M; Bui B; Perreault P; Fenyves D; Willems B; Marleau D; Bilodeau M; Lafortune M; Dufresne MP Gut; 2001 Mar; 48(3):390-6. PubMed ID: 11171831 [TBL] [Abstract][Full Text] [Related]